ストックスクリーナーアプリを入手
417.11
1.56%
6.7563
前日終値:
$410.35
開ける：
$410.32
24時間の取引高:
653.97K
Relative Volume:
0.47
時価総額：
$60.23B
収益：
$2.50B
当期純損益:
$-226.32M
株価収益率:
-254.15
EPS:
-1.6412
ネットキャッシュフロー:
$71.51M
1週間 パフォーマンス:
+1.21%
1か月 パフォーマンス:
+26.99%
6か月 パフォーマンス:
+100.38%
1年 パフォーマンス:
+149.03%
1日の値動き範囲:
$405.24
$419.96
1週間の範囲:
$401.00
$427.47
52週間の値動き範囲:
$167.22
$427.47
Natera Inc Stock (NTRA) Company Profile
Compare NTRA vs TMO, DHR, A, IQV
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
417.87 | 59.47B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
665.97 | 241.26B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
218.09 | 150.48B | 24.78B | 3.68B | 5.29B | 5.1743 |
A
Agilent Technologies Inc
|
169.82 | 48.71B | 7.23B | 1.41B | 1.09B | 4.979 |
IQV
Iqvia Holdings Inc
|
263.30 | 44.50B | 16.63B | 1.39B | 2.12B | 8.0674 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-14 | 開始されました | William Blair | Outperform |
| 2026-01-07 | 開始されました | Citigroup | Buy |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-27 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 再開されました | Wells Fargo | Equal Weight |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
After five sales in three months, a Natera (NTRA) officer proposes another stock sale. - Stock Titan
Natera CEO Steve Chapman: Treatment on Molecular Recurrence Will Reshape Oncology in 5 Years - finance.biggo.com
Natera, Inc. (NTRA) stock price, news, quote and history - Yahoo Finance Australia
Natera, Inc. (NTRA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Natera stock hits all-time high at 422.19 USD - Investing.com
$1000 Invested In Natera 5 Years Ago Would Be Worth This Much Today - Benzinga
Hewlett Packard, Natera, UnitedHealth Group: CNBC ‘Final Trades’UnitedHealth Group (NYSE:UNH) - Benzinga
Form 4 Natera Inc For: 27 September By Investing.com - Investing.com Australia
Form 4 Natera Inc For: 25 September By Investing.com - Investing.com Australia
Form 4 Natera Inc For: 25 September - Investing.com India
Natera director Sheena’s trusts dispose of $7.0m in NTRA stock - Investing.com
Under a preset plan, two trusts sold 18,064 Natera (NTRA) shares in 12 transactions. - Stock Titan
Natera(NTRA.US) Director Sells US$7.01 Million in Common Stock - Moomoo
RBC Capital raises Natera stock price target on MRD testing growth By Investing.com - Investing.com South Africa
Final Trades: Hewlett Packard, Natera and UnitedHealth - CNBC
Natera options flow shows 12.6:1 put/call ratio near 52-week high - Investing.com
NTRA Maintained by RBC Capital -- Price Target Raised to $460 - GuruFocus
RBC Capital raises Natera stock price target on MRD testing growth - Investing.com
Natera Is Maintained at Outperform by RBC Capital - moomoo.com
RBC Capital maintains Outperform rating on Natera, $460 price target - TradingView
Natera’s Critical Pivot to Oncology - Nanalyze
RBC Raises Price Target on Natera to $460 From $350, Keeps Outperform Rating - marketscreener.com
Natera Inc (NTRA) Stock Up 4.6% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Svetlana Nikic Celebrates Natera’s Signatera Milestone in Japan - Oncodaily
Natera stock gains 2.75 percent after Japan test approval - AD HOC NEWS
Has Natera (NTRA) Run Ahead Of Fair Value After Its Japan Signatera Approval? - simplywall.st
Natera Director Sheena Jonathan to Offload 21,064 Shares Worth $8.16M, Form 144 Filed - Kalkine Media
Stocks making big moves yesterday: AutoZone, Natera, Shopify, Twilio, and Lennar - Yahoo Finance
Signatera Surges in Liquid Biopsy Race with New Lung Cancer Data and a Japan Approval - insideprecisionmedicine.com
Form 144 Natera For: 23 September By Investing.com - Investing.com Canada
Natera's Signatera Wins Japan PMDA Approval as Bladder Cancer CDx - Yahoo Finance
$8.2M stock sale planned at Natera (NASDAQ: NTRA) - Stock Titan
Natera, Inc.Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - marketscreener.com
Why Is Natera (NTRA) Stock Soaring Today - Yahoo Finance
A Look at Natera Inc (NTRA) After 5.5% Gain -- GF Value $219.69 vs Price $390.90 - GuruFocus
Behavioral Patterns of NTRA and Institutional Flows - Stock Traders Daily
Natera Inc stock reaches all-time high at 373.58 USD By Investing.com - Investing.com Nigeria
Natera Inc Stock (NTRA) Moved Up by 5.67% on Sep 22: Facts Behind the Movement - TradingKey
Natera gains as fresh Signatera lung cancer data and upbeat analyst sentiment support shares - Quiver Quantitative
NTRA Looks 68.7% Overvalued on GF Value™ - gurufocus.com
Signatera Receives Regulatory Approval in Japan as a Companion Diagnostic in Muscle-Invasive Bladder Cancer - Finviz
Natera’s Signatera Receives Japanese Approval as CDx for Muscle-Invasive Bladder Cancer - GenomeWeb
Natera Inc stock reaches all-time high at 373.58 USD - Investing.com
Natera Says Signatera Commercial Launch In Japan Expected In 1H 2027 - TradingView
Uber, Micron, Datadog And A Health Care Stock: CNBC’s ‘Final Trades’ - Benzinga
A cancer test receives its second Japan approval in three months to guide bladder-cancer treatment. - Stock Titan
Enterprise value to EBITDA ratio of Natera Inc Cert Deposito Arg Repr 0.019607 Sh – BCBA:NTRA.CI - TradingView
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
Natera Inc (NTRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS |
Oct 01 '26 |
Sale |
414.22 |
3,000 |
1,242,645 |
106,914 |
1.01%
大文字化:
|
ボリューム (24 時間):